Guaifenesin / phenylephrine / pyrilamine Pregnancy and Breastfeeding Warnings
Brand names: A-Tan 12X, Ryna-12X
Guaifenesin / phenylephrine / pyrilamine Pregnancy Warnings
Guaifenesin/phenylephrine/pyrilamine has been assigned to a pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Guaifenesin/phenylephrine/pyrilamine is only recommended for use during pregnancy when benefit outweighs risk.
Guaifenesin / phenylephrine / pyrilamine Breastfeeding Warnings
There are no data on the excretion of guaifenesin/phenylephrine/pyrilamine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- Product Information. Ryna-12X (guaifenesin/phenylephrine/pyrilamine). Meda AB. 2003.
References for breastfeeding information
- Product Information. Ryna-12X (guaifenesin/phenylephrine/pyrilamine). Meda AB. 2003.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
